Nosocomial candidaemias due to species other than Candida albicans in cancer patients

Autor:	E. Grey, J. Novotny, A. Sabo, F. Mateicka, L. Sevcikova, A. Kunova, J. Mardiak, D. Sorkovska, Jozef Sufliarsky, L. Jurga, D. West, J. Trupl, Vladimir Krcmery, M. Mrazova
Rok vydání:	1999
Předmět:	medicine.medical_specialty Catheter insertion biology business.industry medicine.disease biology.organism_classification Surgery Oncology Internal medicine medicine Mucositis Antibiotic prophylaxis Risk factor business Candida albicans Empiric therapy Fungemia Fluconazole medicine.drug
Zdroj:	Supportive Care in Cancer. 7:428-431
ISSN:	1433-7339 0941-4355
DOI:	10.1007/s005200050304
Popis:	Forty-five cases of fungaemia due non-albicans Candida spp. (NAC) in a single National Cancer Institution within 10 years were analysed for aetiology, risk factors and outcome. There had been 12 cases of fungaemia that were due to C. krusei, 14 due to C. parapsilosis, 7 due to C. (T.) glabrata, 6 to C. tropicalis, 2 to C. guillermondii, 2 to C. lusitaniae, 1 to C. stellatoidea, and 1 to C. rugosa. Comparison of 45 NAC fungaemia with 75 episodes of C. albicans fungaemia revealed differences only in two risk factors: previous empiric therapy with amphotericin B (16.0 vs 2.2%, P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2864ef6c48af00b73502194762a80fd7 https://doi.org/10.1007/s005200050304 Zobrazit plný text záznamu Full text from SpringerLink